Barr was founded in the year 1970 in New York, USA as one of the pioneer pharmaceutical companies of the nation. The company introduced its very first generic formulation during the year 1972 and became one of the earliest manufacturers of the antibiotic medication products. Anyway, it is known that the overall generic pharmaceutical business flourished only over a decade later. 

 

Barr Pharmaceuticals Inc is one of the group companies owned by Delaware holdings besides its major ancillaries such as Barr Laboratories Inc and Duramed Pharmaceuticals Inc that develop, produce and commercialize various generic and patent pharmaceutical formulations in that order. The generic products of the company are sold under the make of Barr and all the patented medications through Duramed make.     

 

The flagship constituent of the group known as Duramed is presently selling nineteen patented or proprietary formulation preparations that include: Seasonique, Enjuvia, Plan B, ParaGard T380A IUD, and Mircette. Whereas another member company called Barr currently takes care of managing sales of seventy five generic pharmaceutical formulation products in almost one hundred and fifty dosage forms and strengths which include twenty two oral contraceptive products.

 

All such products are being produced in tablet and capsule forms at present. The major popular generic pharmaceutical products of the company being sold in the markets include: Extended Oral Contraceptives like Enjuvia and Warfarin Sodium. It has been reported that the company has achieved the record net earnings to the tune of 337 million USD on its revenues of 1.3 billion USD during the fiscal year ended on 30^th June, 2006.